Emerald Advisers’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
|
|||||
2021
Q2 | $18.5M | Sell |
|
|||||
2021
Q1 | $13.4M | Sell |
|
|||||
2020
Q4 | $12.9M | Buy |
|
|||||
2020
Q3 | $9.31M | Sell |
|
|||||
2020
Q2 | $13.2M | Sell |
|
|||||
2020
Q1 | $12.3M | Sell |
|
|||||
2019
Q4 | $15.5M | Sell |
|
|||||
2019
Q3 | $12.5M | Sell |
|
|||||
2019
Q2 | $15.5M | Sell |
|
|||||
2019
Q1 | $14.6M | Sell |
|
|||||
2018
Q4 | $10.8M | Buy |
|
|||||
2018
Q3 | $14.8M | Buy |
|
|||||
2018
Q2 | $7.39M | Buy |
|
|||||
2018
Q1 | $274K | Sell |
|
|||||
2017
Q4 | $266K | Buy |
|
|||||
2015
Q2 | – | Sell |
|
|||||
2015
Q1 | $1.55M | Buy |
|